# Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone

> **NCT01702701** · PHASE3 · WITHDRAWN · sponsor: **Medical College of Wisconsin**

## Conditions studied

- Eosinophilic Esophagitis
- Dysphagia

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT01702701
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702701, "Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01702701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*